Lunch and Focused Sessions – Block V of V

Concurrent Events

• 01:00 PM - 01:40 PM

  AI Diagnostics | Is the Future of Diagnostics Moving “In Silico”?

  Moderator

  Danielle Bitterman, MD,

  Radiation Oncologist, Brigham and Women's Hospital;

  Assistant Professor of Radiation Oncology, Harvard Medical School

  Speakers

  Andy Beck, MD, PhD,

  CEO, PathAI

  Jacob Donoghue, MD, PhD,

  CEO, Beacon Biosignals

  Connie Lehman, MD, PhD,

  Founder, Clairity;

  Professor of Radiology, Harvard Medical School

  Jay Rughani,

  Investing Partner, Andreessen Horowitz

  David Spetzler, PhD,

  President, Caris Life Sciences

• 01:00 PM - 01:40 PM

  Tackling High Priority Health Challenges in Underserved Communities

  Moderator

  Elsie Taveras, MD,

  Chief Community Health & Health Equity Officer, Mass General Brigham;

  Executive Director, Kraft Center for Community Health;

  Conrad Taff Endowed Chair and Professor of Pediatrics, Harvard Medical School

  Speakers

  Alisha Lalani,

  Chief Growth Officer, Mae Health

  Kwamane Liddell,

  Founder & CEO, ThriveLink

  Christopher Thompson,

  Founder, Sober Sidekick

  Jeffrey Yang, MD,

  Thoracic Surgeon; Founding Director, Center for Artificial Intelligence & Innovation Research, Mass General Brigham;

  Associate Professor of Surgery, Harvard Medical School

• 01:00 PM - 01:40 PM

  Upending the US Care Delivery and Medical Research Model | Planning for Excellence After the Cuts

  Moderator

  Niyum Gandhi,

  CFO & Treasurer, Mass General Brigham

  Speakers

  Kiame Mahaniah, MD,

  Secretary of Health and Human Services, Commonwealth of Massachusetts

  John Orsini,

  EVP & CFO, Northwestern Memorial HealthCare

  Laura Peabody,

  Chief Legal Officer, Mass General Brigham

• 01:00 PM - 01:40 PM

  Institutional Investor LP Perspective | Opportunities & Challenges in Today’s Healthcare Investment Landscape

  Moderator

  Emma Somers-Roy,

  Chief Investment Officer, Mass General Brigham

  Speakers

  Letitia Johnson,

  Chief Investment Officer, Amherst College

  Paul Mace,

  Managing Director, Williams College Investment Office

  Adam Posner,

  Co-Head of Public Markets, HighVista Strategies

• 01:00 PM - 01:40 PM

  Picasso Ballroom

  Emerging Treatments

  Emerging Treatments | Hematological Cancers

  Moderators

  Tim Anderson, MD,

  Pharmaceutical Analyst, BofA Securities

  Alec Stranahan,

  SMid-Cap Biotech Analyst, BofA Securities

  Speakers

  Amir Fathi, MD,

  Director, Leukemia Program, Massachusetts General Hospital;

  Associate Professor of Medicine, Harvard Medical School

  Matthew Frigault, MD,

  Massachusetts General Hospital

  Connor Johnson, MD,

  Assistant Professor of Medicine, Massachusetts General Hospital & Harvard Medical School

  Andrew Yee, MD,

  Massachusetts General Hospital